期刊文献+

人工合成mutacin的抑菌活性研究 被引量:2

Study of antimicrobial effects of synthetic peptide mutacin from Streptococcus mutans in vitro
暂未订购
导出
摘要 目的:研究人工合成mutacinⅠ和Ⅲ对牙菌斑主要致龋菌的抑制作用,寻找其活性基团。方法:通过固相合成法合成mutacinⅠ和Ⅲ及不同链长的系列短肽。采用二倍稀释法检测系列短肽对变形链球菌和血链球菌的最小抑菌浓度,并检测其对变形链球菌、血链球菌、韦荣氏菌、黏性放线菌、内氏放线菌、远缘链球菌的抑菌圈直径大小。结果:人工合成mutacinⅠ和Ⅲ及部分短肽类似物对变形链球菌、远缘链球菌、血链球菌有抑菌活性。结论:人工合成的mutacinⅠ和Ⅲ及部分短肽类似物有一定的抑菌活性,可初步确定其活性基团位置。 AIM: To study the antimicrobial activity of peptide mutacin Ⅰ and Ⅲ and short peptide and detect the active group in vitro. METHODS: The peptide mutacin from S. mutans was synthesized by Merrifold peptide synthesor. Its amino acid sequence was detected by Fast technique. The antibiotic activities of peptide mutacin Ⅰ and Ⅲ and short peptide against Streptococcus mutaus, Streptococcus sobrinus, Streptococcus sanguis, Actinomyces naeslundi, Actinomyces viscosus were tested by drug sensitive slips method and double dilution method. RESULTS: The peptide mutacin Ⅰ and Ⅲ and short peptides only have bactericidal activity against Streptococcus mutaus, Streptococcus sobrinus and Streptococcus sanguis. CONCLUSIONS: The peptide mutacin Ⅰ and Ⅲ and some of short peptides have bactericidal activity. Some short peptides may be the active group.
出处 《牙体牙髓牙周病学杂志》 CAS 2007年第6期333-336,共4页 Chinese Journal of Conservative Dentistry
基金 陕西省科学技术研究发展计划项目资助[2004K11-G3(3)]
关键词 MUTACIN 多肽 抑菌实验 mutacin peptides In vitro experiment
  • 相关文献

参考文献10

  • 1Caufield PW,Childers NK,Allen DN,et al.Distinct bacterioc in groups correlate with different of streptococcus mutans plasmids[J].Infect Irmnun,1985,48(1)51-56
  • 2Aoba T.Slrategres for improving the easement of dental fluorosis:focus chemical and biochemical aspects[J].Adv Dent Res,1994,(8)66-74
  • 3La Lu mandier JA.The prevalence and risk factors of fluorosis among patients in a pediatric dental practice[J].Pediatr Dent,1995,(7)19-25
  • 4Haug BE,Stensen W,Stiberg T,et al.Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides[J].J Med Chem,2004,47(17):4159-4162
  • 5Otvos L,Wade JD,Lin F,et al.Design er an tibacterial peptides kill fluoroquinolone-resistant clinical isolates[J].J Med Chem,2005,48(16)5349-5359
  • 6丁芸,凌均棨,陈罕.人工合成多肽防龋疫苗HDS的研究——I多肽HDS序列合成和鉴定[J].实用口腔医学杂志,2003,19(4):343-345. 被引量:5
  • 7Bal-krishnan M,Simmonds RS,Tagg JR.Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci[J].Caries Research,2001,35(1):75-80
  • 8Qi F,Chen P,Caufield PW.Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans,CH43,and genetic analysis of mutacin I bio-synthesis genes[J].Appl Environ Microbiol,2000,66(8):3221
  • 9Qi F,Chen P,Caufield PW.Purification of Mutacin Ⅲ from Group ⅢStreptococcus mutans UA787 and genetic analyses of mutacin Ⅲ biosynthesis genes[J].Appl Environ Microbiol,1999,65(9):3880
  • 10李颂,刘天佳.变链素研究进展[J].国外医学(口腔医学分册),2003,30(5):341-343. 被引量:5

二级参考文献23

  • 1Monchois V, Vignon M, Russel RRB. Mutagenesis of asp-569 of glucosyltransferase I glucansucrase modulates glucan and oligosaccharide synthesis. Appl Enivron Microbiol,2000,66(5) : 1923.
  • 2MacGregor EA, Jespersen HM, Svensson B. A circularly permuted α-amylase-type alpha/beta- barrel structure in glucan-synthesizing glucosyltranferase. FEBS lett, 1996, 378(3): 263.
  • 3Tsumori H, Minai T, Kuramitsu HK. Identification of essential amnio acids in the Streptococcus mutans glucosyltransferases. J Bactoeriol, 1997,179(11): 3391.
  • 4Shimamura A, Nakano YJ, Mukasa H, et al. Identification of amino acid residues in Streptococcus mutans glucosyltransferases influencing the structure of the glucan product.J Bacteriol, 1994,176(16) : 4845.
  • 5Smith DJ, Shousthtari B, Heachel RL, et al. Immunogenicity and proctective immunity induced by synthetic peptides associated with a catalytic suhdomain of mutans group streptococcal glucosyltransferase. Infect Immun, 1997,65 (11) :4424.
  • 6McGhee JR, Michalek SM, Webb J, et al. Effective immunity to dental caries: Protection of gnotobiotic rats by local immunization with Streptococcus rnutans. J Immunol, 1975,114(1) : 300.
  • 7Van de Rijn I, Bleiweis AS, Zabriskie JB. Antigens in Streptococcus mutans cross reactive with human heart muscle. J Dent Res, 1976,55( Sepc issue) : C59.
  • 8Jack RW, Tagg JR, Ray B. Microbiol Rev, 1995, 59:171-200.
  • 9Nissen-Meyer J, Nes IF. Arch Microbiol, 1997, 167:67-77.
  • 10Said HG, Bierbaum G. Annu Rev Microbiol, 1998, 52:41-79.

共引文献8

同被引文献32

  • 1石馨,倪龙兴,田宇,邝容.变形链球菌CH43变链素Ⅰ基因片段的克隆及表达[J].实用口腔医学杂志,2005,21(3):339-342. 被引量:3
  • 2李领,刘天佳,胡晓燕,杨柳,柳雯.变链素活性与变形链球菌基因多态性的关系研究[J].中国微生态学杂志,2007,19(3):253-255. 被引量:4
  • 3HALE J D,TING Y T,JACK R W,et al. Bacteriocin (mutacin) production by Streptococcus rnutans genome sequence reference strain UA159 :elucidation of the antimicrobial repertoire by genetic dissection [ J]. Appl Environ Microbio1,2005,71 ( 11 ) :7613-7617.
  • 4BALAKRISHNAN M, SIMMONDS R S, KILIAN M, et al. Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenet- ic lineages[ J]. J Med Micrebiol,2002,51 ( 11 ) :941-948.
  • 5QI F, MERRITTJ, LUX R, et al. Inactivation of the ciaH Gene in Streptococcus mutans diminishes mutacin production and competence development, alters sucrose-dependent biofilm formation, and reduces stress tolerance[ J ]Infect Immun ,2004,72 (8) :4895 A899.
  • 6MOTA-MERIA M, LaPOINTE G, LACROIX C, et al. MICs of mutacin B-Ny266 ,nisin A, vancomycin, and oxacillin against bacterial pathogens[ J]. Antimicrob Agents Chemother,2000,44 ( 1 ) :24-29.
  • 7QI F, CHEN P, CAUFIELD P W. Purification of mutaein Ⅲ from group Ⅲ streptococcus rnutans UA787 and genetic analyses of mutacin Ⅲ biosynthesis genes [ J ]. Appl Environm Mierobiol, 1999, 65 ( 9 ) : 3880-3887.
  • 8HAMADA S, OOSHIMA T. Inhibitory spectrum of a bactefiocinlike substance (mutacin) produced by some strains of Streptococcus mutans [ J ]. J Dent Res, 1975,54 ( 1 ) : 140-145.
  • 9QI F, CHEN P, CAUFIELD P W. The group I strain of Streptococcus mutans, UA140, produces both the lantibiofic mutacin Ⅰ and a nonlantibiotic bacteriocin, mutacin Ⅳ[ J ]. Appl Environm Microbiol, 2001,67 (1) :15-21.
  • 10NOVXK J, CAUFIELD P W, MILLER E J. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus nuaans [J]. J Bacteriol,1994,176(14) :4316-4320.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部